BiotechTube
Home/Pulmovant/Drew Fromkin
DF

Drew Fromkin

Chief Executive Officer

Pulmovant

Therapeutic Areas

Pulmonary HypertensionInterstitial Lung Disease

Pulmovant Pipeline

DrugIndicationPhase
mosliciguatPulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD)Phase 2